Holiday Meeting Schedule – President’s Day

February 6, 2018

Due to the upcoming President’s Day holiday, some review timelines and meeting dates have been modified.

Read Article >

Advarra and TransPerfect Form Strategic Language Services Partnership

January 31, 2018

TransPerfect Life Sciences, a leading provider of technologies and services to support clinical trials and product development for the biopharmaceutical industry, today announced that it has been selected as the official language services provider for Advarra.

Read Article >

Effective Date and General Compliance Date for Revised Common Rule Delayed 6 Months

January 24, 2018

The Department of Health and Human Services (HHS) and 15 other agencies have issued an Interim Final Rule (IFR) that applies a 6 month delay to the effective date and general compliance date of the revisions to the “Federal Policy for the Protection of Human Subjects” (also known as the Common Rule) originally published in the Federal Register on January 19, 2017 (82 FR 7149).

Read Article >

Legal Notice of Name Change

January 9, 2018

Both Schulman IRB and Chesapeake IRB will retain d/b/a status for an interim period and continue to operate under the current structure. Beginning in January 2018, customers will be contacted to amend and assign contracts as necessary. No action is required from you at this time.

Read Article >

Integrated Advarra Fee Schedule Now Available

December 20, 2017

As a part of ongoing integration efforts, Schulman IRB and Chesapeake IRB have developed a joint Fee Schedule for the combined Advarra organization. This Fee Schedule is effective January 1, 2018.

Read Article >

Holiday IRB Meeting Schedule – Winter Holidays

December 11, 2017

Due to the upcoming winter holiday season, some review timelines and IRB meeting dates have been modified.

Read Article >

Schulman IRB and Chesapeake IRB Merger and Integration: What You Need to Know

By: Julie Blasingim, Director of Change Management at Schulman IRB, and Lauri Carlile, Executive Director at Chesapeake IRB
November 30, 2017

On November 7, 2017, we announced that Chesapeake IRB and Schulman IRB are merging under the new organizational name, Advarra. As we proceed through the integration process, we are committed to providing proactive answers and support to our clients so that you have the information you need to continue your work with as little interruption as possible. With this in mind, we’ve assembled an FAQ article to address some of your most commonly asked questions.

Read Article >

Chesapeake expands services to meet growing demand

By: Melissa Fassbender
Published in:
June 7, 2017


Jeff Wendel, President and CEO of Chesapeake IRB discusses the growth strategy of Chesapeake IRB and the acquisitions of Institutional Biosafety Corporation and MaGil IRB.

Read Article >

Using Technology to Support NIH Policy

By: Jeffrey Wendel
Published in: Applied Clinical Trials
September 29, 2016

Chesapeake IRB’s president, Jeffrey Wendel, discusses the importance of choosing the right technology to support clinical research trials after the approval of the National Institute of Health’s policy: Use of a Single Institutional Review Board of Record for Multi-Site Research.

Read Article >